Work

New Hope for Mobilization Failures . . . Again

Year: 2011

Type: article

Abstract: Patients undergoing peripheral blood stem cell mobilization for autologous transplantation may fail to achieve the generally accepted minimum threshold for transplantation (≥2 × 106 CD34/kg) despite using optimal doses of granulocyte-colony stimiulating factor (G-CSF) or chemotherapy plus G-CSF. Failure rates vary from center to center but are felt to be highest in certain diseases such as non-Hodgkin’s lymphoma (NHL), Hodgkin’s disease (HD), and in heavily pretreated patients with multiple myeloma (MM).

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2011.12.578

Author: John F. DiPersio

Institutions: Washington University in St. Louis, Alvin J. Siteman Cancer Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650